Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04476329
Title Optimization for Regorafenib in HCC (ReDos HCC)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors SC Liver Research Consortium, LLC
Indications

hepatocellular carcinoma

Therapies

Regorafenib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.